Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
Category:
29 January 2021
PUBLICATION OF THE 2021 CORPORATE EVENTS CALENDAR
18 January 2021
PHARMANUTRA S.P.A. APPOINTS A SUPERVISORY BODY
22 December 2020
CETILARĀ® PATCH AND CETILARĀ® TAPE CERTIFIED CLASS 2A MEDICAL DEVICES
11 December 2020
BORSA ITALIANA ORDERS ADMISSION OF THE ORDINARY SHARES OF PHARMANUTRA TO TRADING ON THE MTA – STAR SEGMENT
11 December 2020
THE INFORMATION PROSPECTUS ON ADMISSION TO TRADING ON THE MTA – STAR SEGMENT HAS BEEN PUBLISHED
11 December 2020
CONSOB APPROVES THE INFORMATION PROSPECTUS FOR ADMISSION TO TRADING ON MTA – STAR SEGMENT
04 December 2020
BORSA ITALIANA DISPONE LāAMMISSIONE A QUOTAZIONE SUL MERCATO MTA DELLE AZIONI ORDINARIE DI PHARMANUTRA S.P.A.
01 December 2020
PHARMANUTRA S.P.A.: NEW DISTRIBUTION AGREEMENT FOR BRAZIL
18 November 2020
PHARMANUTRA S.P.A.: NEW INTERNATIONAL DISTRIBUTION AGREEMENTS
11 November 2020
PHARMANUTRA S.P.A.: REGISTRATION OF THE BRANDS CETILARĀ® AND SIDERALĀ® GRANTED IN THE USA
09 November 2020
PHARMANUTRA S.P.A.: CONSOLIDATED FINANCIAL REPORT AS AT 30TH SEPTEMBER 2020
06 November 2020
PHARMANUTRA S.P.A.: AGGIORNAMENTO CALENDARIO EVENTI SOCIETARI 2020
03 November 2020
PHARMANUTRA S.P.A. PRESENTS A NEW CETILARĀ® LINE PRODUCT
27 October 2020
MTA STAR LISTING PROCESS: AMENDMENT TO THE EXISTING SHAREHOLDERSā AGREEMENT AND COMMITMENT TO THE 36 MONTHS LOCK UP
23 October 2020
THE MTA STAR LISTING PROCESS: BOD OF PHARMANUTRA S.P.A.
13 October 2020
ORDINARY AND EXTRAORDINARY SHAREHOLDERSā MEETING AND BOARD OF DIRECTORSā MEETING DOWNSTREAM OF THE SHAREHOLDERSā MEETING
25 September 2020
COOPTAZIONE DI DUE CONSIGLIERI DI AMMINISTRAZIONE INDIPENDENTI E CONVOCAZIONE DELLāASSEMBLEA DEGLI AZIONISTI
25 September 2020
COMUNICAZIONE AI SENSI DELLāART. 17 DEL REGOLAMENTO EMITTENTI AIM ITALIA
24 September 2020
INCREMENTO DEL FLOTTANTE AI FINI DELLA QUOTAZIONE SUL SEGMENTO STAR DEL MTA ATTRAVERSO CESSIONI DI PARTECIPAZIONI DEI SOCI DI RIFERIMENTO
21 September 2020
LAUNCH OF THE MTA STAR SEGMENT LISTING APPROVED BY THE BOARD OF DIRECTORS
14 September 2020
EXCEPTIONAL RESULTS IN THE FIRST HALF OF 2020. DOUBLE DIGIT GROWTH.
<
1
…
5
6
7
…
11
>
